Establishment Labs Holdings (ESTA) Operating Margin Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 241.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn | 3,008.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,008.00 |
| Dec 31, 2025 | 3,586.00 |
| Sep 30, 2025 | 2,518.00 |
| Jun 30, 2025 | -632.00 |
| Mar 31, 2025 | -1,719.00 |
| Dec 31, 2024 | 2,813.00 |
| Sep 30, 2024 | 2,197.00 |
| Jun 30, 2024 | 706.00 |
| Mar 31, 2024 | -623.00 |
| Dec 31, 2023 | -4,004.00 |
| Sep 30, 2023 | -2,714.00 |
| Jun 30, 2023 | -298.00 |
| Mar 31, 2023 | -304.00 |
| Dec 31, 2022 | -351.00 |
| Sep 30, 2022 | 365.00 |
| Jun 30, 2022 | -1,078.00 |
| Mar 31, 2022 | -759.00 |
| Dec 31, 2021 | 321.00 |
| Sep 30, 2021 | -1,976.00 |
| Jun 30, 2021 | 7,720.00 |
| Mar 31, 2021 | 2,456.00 |
| Dec 31, 2020 | -1,157.00 |
| Sep 30, 2020 | 2,697.00 |
| Jun 30, 2020 | -4,841.00 |
| Mar 31, 2020 | 890.00 |
| Dec 31, 2019 | 3,441.00 |
| Sep 30, 2019 | -123.00 |
| Jun 30, 2019 | 281.00 |
| Mar 31, 2019 | -2,093.00 |
| Dec 31, 2018 | -1,373.00 |
| Sep 30, 2018 | 4,440.00 |
| Jun 30, 2018 | 1,747.00 |